Related Experiment Video
Updated: Aug 11, 2026

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
Published on: July 19, 2018
Peritonitis caused by Mycobacterium kansasii in a patient undergoing continuous ambulatory peritoneal dialysis
M Giladi1, B E Lee, O G Berlin
1Department of Medicine, UCLA School of Medicine.
Abstract:
Mycobacterium kansasii was isolated from the peritoneal fluid, peritoneal biopsy, and the Tenckhoff catheter of a 62-year-old woman undergoing continuous ambulatory peritoneal dialysis (CAPD) who presented with the clinical picture of peritonitis. To the best of our knowledge, this is the first case of CAPD-associated peritonitis caused by M kansasii. Routine susceptibility tests using standard concentrations of isoniazid indicated isoniazid resistance; however, the organism was inhibited in vitro by a higher concentration of this drug. The patient responded to combination therapy with isoniazid and rifampin, as well as removal of the catheter. This report emphasizes the importance of mycobacterial cultures, in certain circumstances, in patients with CAPD-associated peritonitis and the utility of quantitative in vitro susceptibility testing.
Insights
Mycobacterium kansasii caused peritonitis in a continuous ambulatory peritoneal dialysis (CAPD) patient. Early diagnosis and tailored antimicrobial therapy, including higher-dose isoniazid, are crucial for successful treatment.
Area of Science:
- Infectious Diseases
- Nephrology
- Microbiology
Background:
- Continuous ambulatory peritoneal dialysis (CAPD) is a treatment for end-stage renal disease.
- Peritonitis is a serious complication of CAPD, often caused by common bacteria.
- Atypical mycobacterial infections are rare but significant causes of CAPD peritonitis.
Observation:
- A 62-year-old female CAPD patient presented with clinical peritonitis.
- Mycobacterium kansasii was identified in peritoneal fluid, biopsy, and Tenckhoff catheter.
- Standard susceptibility testing indicated isoniazid resistance, but higher concentrations showed in vitro inhibition.
Findings:
- This is the first reported case of CAPD-associated peritonitis caused by Mycobacterium kansasii.
- The patient achieved clinical improvement with a combination therapy of isoniazid and rifampin.
- Catheter removal was also a critical component of the treatment regimen.
Implications:
- Highlights the importance of considering mycobacterial infections in refractory or atypical CAPD peritonitis cases.
- Underscores the need for quantitative in vitro susceptibility testing for optimizing antimicrobial therapy.
- Suggests that higher isoniazid concentrations may be effective against certain resistant strains of M. kansasii.
Related Concept Videos
Peritoneal Dialysis I: Introduction and Procedure
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Continuous Renal Replacement Therapy
Kidney Transplant II: Surgical Procedure
Acute Kidney Injury V: Interprofessional Care
Amebiasis

